KVP Capital Advisors’s Sutro Biopharma STRO Stock Holding History

KVP Capital Advisors’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.52M	Hold	226,575	–	–	5.52%	5
2026 Q1	$5.64M	Buy	+226,575	New	+$4.09M	4.22%	5

Other funds holding STRO

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

KVP Capital Advisors's STRO Position: Q2 2026 in Review

KVP Capital Advisors held its Sutro Biopharma (STRO) position steady in Q2 2026 at 226,575 shares worth $7.52M. The position accounts for 5.52% of the portfolio, ranked #5.

KVP Capital Advisors first reported a position in STRO in Q1 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

KVP Capital Advisors held 226,575 shares of Sutro Biopharma worth $7.52M as of Q2 2026.
KVP Capital Advisors left its Sutro Biopharma share count unchanged in Q2 2026.
Sutro Biopharma made up 5.52% of KVP Capital Advisors's portfolio in Q2 2026, its #5 holding.
KVP Capital Advisors first reported a position in Sutro Biopharma in Q1 2026 and has held it in 2 quarters since.
100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.